Literature DB >> 25338257

[Causes for the underreporting of adverse drug events by health professionals: a systematic review].

Fabiana Rossi Varallo1, Synara de Oliveira Paim Guimarães1, Samir Antonio Rodrigues Abjaude1, Patricia de Carvalho Mastroianni1.   

Abstract

OBJECTIVE: Identifying the main causes for underreporting of Adverse Drug Reaction (ADR) by health professionals.
METHOD: A systematic review carried out in the following databases: LILACS, PAHO, SciELO, EMBASE and PubMed in the period between 1992 and 2012. Descriptors were used in the search for articles, and the identified causes of underreporting were analyzed according to the classification of Inman.
RESULTS: In total, were identified 149 articles, among which 29 were selected. Most studies were carried out in hospitals (24/29) for physicians (22/29), and pharmacists (10/29). The main causes related to underreporting were ignorance (24/29), insecurity (24/29) and indifference (23/29).
CONCLUSION: The data show the eighth sin in underreporting, which is the lack of training in pharmacovigilance. Therefore, continuing education can increase adherence of professionals to the service and improve knowledge and communication of risks due to drug use.

Entities:  

Mesh:

Year:  2014        PMID: 25338257     DOI: 10.1590/s0080-623420140000400023

Source DB:  PubMed          Journal:  Rev Esc Enferm USP        ISSN: 0080-6234            Impact factor:   1.086


  30 in total

1.  Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey.

Authors:  Choki Dorji; Pramote Tragulpiankit; Arthorn Riewpaiboon; Tashi Tobgay
Journal:  Drug Saf       Date:  2016-12       Impact factor: 5.606

Review 2.  Adverse drug event reporting systems: a systematic review.

Authors:  Chantelle Bailey; David Peddie; Maeve E Wickham; Katherin Badke; Serena S Small; Mary M Doyle-Waters; Ellen Balka; Corinne M Hohl
Journal:  Br J Clin Pharmacol       Date:  2016-05-09       Impact factor: 4.335

Review 3.  Factors affecting patient reporting of adverse drug reactions: a systematic review.

Authors:  Rania Al Dweik; Dawn Stacey; Dafna Kohen; Sanni Yaya
Journal:  Br J Clin Pharmacol       Date:  2016-11-25       Impact factor: 4.335

4.  An observational study to assess the possibility of patient participation in implementing pharmacovigilance in a busy tertiary care hospital.

Authors:  A Tejus; A G Mathur; R Vishnuprasad; Akansha Singh; Sapna Pradhan
Journal:  Med J Armed Forces India       Date:  2019-12-16

5.  The effect of clinical pharmacists' intervention in adverse drug reaction reporting: a retrospective analysis with a 9-year interrupted time series.

Authors:  Tianwei Lan; Hua Wang; Xin Li; Hang Yin; Dan Shao; Yueyao Jiang; Qian Yu
Journal:  BMC Health Serv Res       Date:  2022-07-19       Impact factor: 2.908

6.  A Survey of Adverse Event Reporting Practices Among US Healthcare Professionals.

Authors:  Stella Stergiopoulos; Carrie A Brown; Thomas Felix; Gustavo Grampp; Kenneth A Getz
Journal:  Drug Saf       Date:  2016-11       Impact factor: 5.606

7.  Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in Kuwait.

Authors:  Fatemah M Alsaleh; Sherifah W Alzaid; Eman A Abahussain; Tania Bayoud; Jacinthe Lemay
Journal:  Saudi Pharm J       Date:  2016-12-26       Impact factor: 4.330

8.  Descriptions of Adverse Drug Reactions Are Less Informative in Forums Than in the French Pharmacovigilance Database but Provide More Unexpected Reactions.

Authors:  Pierre Karapetiantz; Florelle Bellet; Bissan Audeh; Jérémy Lardon; Damien Leprovost; Rim Aboukhamis; François Morlane-Hondère; Cyril Grouin; Anita Burgun; Sandrine Katsahian; Marie-Christine Jaulent; Marie-Noëlle Beyens; Agnès Lillo-Le Louët; Cédric Bousquet
Journal:  Front Pharmacol       Date:  2018-05-01       Impact factor: 5.810

9.  Predicting the Reasons of Customer Complaints: A First Step Toward Anticipating Quality Issues of In Vitro Diagnostics Assays with Machine Learning.

Authors:  Stephane Aris-Brosou; James Kim; Li Li; Hui Liu
Journal:  JMIR Med Inform       Date:  2018-05-15

10.  Why Clinicians Don't Report Adverse Drug Events: Qualitative Study.

Authors:  Corinne M Hohl; Serena S Small; David Peddie; Katherin Badke; Ellen Balka; Chantelle Bailey
Journal:  JMIR Public Health Surveill       Date:  2018-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.